Manufacturing news briefs – stories you might have missed
Covid-19 hits Cann Group’s outlook Medicinal cannabis manufacturer Cann Group has been hit by Covid-19 interruptions to supply chains, forcing the company to downgrade its earnings outlook for the year. International regulatory timelines for approval have blown out and third-party manufacturing and supply issues have caused temporary delays in shipments to local and export customers.…
Details